Mechanism of Histone Deacetylase Inhibitors for Treatment of Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis(IPF) is a chronic, progressive, and fibrotic interstitial lung disease. In recent years, with the in-depth study of the pathological mechanism of IPF, more and more drug treatment targets for IPF have been discovered. Studies have shown that the dysregulation of epigene...
Saved in:
| Main Authors: | ZHOU Jia, LI Long, LIAO Jing |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-02-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01) -
The dual antioxidant chitosan oligosaccharides regulate the transdifferentiation of lung effector cells in the management of idiopathic pulmonary fibrosis
by: Huan He, et al.
Published: (2025-06-01) -
Design, Synthesis, and Preliminary Antiproliferative Evaluation of 1,2,4-Thiadiazole Derivatives as Possible Histone Deacetylase Inhibitors
by: Rusul Mohammed Hasan Ali, et al.
Published: (2025-02-01) -
Research advances of histone deacetylases in acute kidney injury
by: Deng Fang-jing, et al.
Published: (2022-04-01) -
Novel histone deacetylase-5 inhibitor T2943 exerts an anti-depressive effect in mice by enhancing GRID1 expression
by: Juan Du, et al.
Published: (2025-02-01)